Healthy Volunteers Clinical Trial
— Ramadan_16Official title:
The Influence of a Modified Ramadan Fasting Regimen on Health and Well-being in Healthy Muslims - a Randomised Controlled Trial
| NCT number | NCT02775175 |
| Other study ID # | 15-6336-BO |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | May 2016 |
| Est. completion date | October 2016 |
| Verified date | April 2018 |
| Source | Universität Duisburg-Essen |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
In this study the investigators will test the impact of a modified Ramadan Fasting regimen on health and well-being. The 2016 Ramadan is around summer solstice in Germany making it one of the most challenging fasting periods for participating Muslims. The modified Ramadan Fasting consists of educational components around fasting, and advice for nutritional modifications in order to support health and well-being during Ramadan, while the control group will continue to fast as usual. The investigators will measure not only body weight/fat but also include measures of psychological well-being, and spiritual practice, and serum markers for blood lipids, and blood sugar. With this trial the investigators aim to determine, whether such modifications around Ramadan will be beneficial for health and well-being.
| Status | Completed |
| Enrollment | 114 |
| Est. completion date | October 2016 |
| Est. primary completion date | July 2016 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years to 60 Years |
| Eligibility |
Inclusion Criteria: - Healthy Muslims participating in Ramadan Fasting - No first time fasting Exclusion Criteria: - Untreated or malign hypertension - Eating disorder - psychological disorder (e.g. depression, schizophrenia, addiction) - co-morbid disease (e.g. diabetes, cancer, gout) - pregnancy - breastfeeding women - BMI under 20 or above 40 - recently on a diet |
| Country | Name | City | State |
|---|---|---|---|
| Germany | Department of Internal and Integrative Medicine, Kliniken Essen-Mitte | Essen |
| Lead Sponsor | Collaborator |
|---|---|
| Universität Duisburg-Essen |
Germany,
Lauche R, Fathi I, Saddat C, Klose P, Al-Abtah J, Büssing A, Rampp T, Dobos G, Cramer H. The effects of Ramadan fasting on physical and mental health in healthy adult Muslims - Study protocol for a randomised controlled trial. Advances in Integrative Medicine, 2016, 3 (1), 26 - 30. doi: 10.1016/j.aimed.2016.07.001
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Quality of life | Quality of life, measured by the WHO-5 (World Health Organisation, Allgaier et al., 2011, WHO-5, 1998) WHO-5, Fragebogen zum Wohlbefinden (Version 1998), Psychiatric Research Unit, WHO Collaborating Centre in Mental Health, http://www.who-5.org/. |
4 weeks | |
| Secondary | Quality of life | Quality of life, measured by the WHO-5 (World Health Organisation, Allgaier et al., 2011, WHO-5, 1998) WHO-5, Fragebogen zum Wohlbefinden (Version 1998), Psychiatric Research Unit, WHO Collaborating Centre in Mental Health, http://www.who-5.org/. |
16 weeks | |
| Secondary | Satisfaction with life | Satisfaction with life, measured by the BMLSS-10 (Brief Multidimensional Life Satisfaction Scale) Büssing A, Fischer J, Haller A, Heusser P, Ostermann T, Matthiessen PF: Validation of the brief multidimensional life satisfaction scale in patients with chronic diseases. European Journal of Medicine Research 2009; 14: 171-177 |
4 weeks | |
| Secondary | Satisfaction with life | Satisfaction with life, measured by the BMLSS-10 (Brief Multidimensional Life Satisfaction Scale) Büssing A, Fischer J, Haller A, Heusser P, Ostermann T, Matthiessen PF: Validation of the brief multidimensional life satisfaction scale in patients with chronic diseases. European Journal of Medicine Research 2009; 14: 171-177 |
12 weeks | |
| Secondary | Spirituality | Spirituality, measured by the SpREUK-P SF17 (Spiritual and Religious Attitudes in Dealing with Illness) Büssing A, Reiser F, Michalsen A, Baumann K: Engagement of patients with chronic diseases in spiritual and secular forms of practice: Results with the shortened SpREUK-P SF17 Questionnaire. Integrative Medicine: A Clinician´s Journal 2012; 11(1):28-38 |
4 weeks | |
| Secondary | Spirituality | Spirituality, measured by the SpREUK-P SF17 (Spiritual and Religious Attitudes in Dealing with Illness) Büssing A, Reiser F, Michalsen A, Baumann K: Engagement of patients with chronic diseases in spiritual and secular forms of practice: Results with the shortened SpREUK-P SF17 Questionnaire. Integrative Medicine: A Clinician´s Journal 2012; 11(1):28-38 |
12 weeks | |
| Secondary | Sleep quality | Sleep quality, measured by the PROMIS Sleep Disturbances and Sleep-related impairment questionnaires Yu L, Buysse DJ, Germain A, Moul DE, Stover A, Dodds NE, Johnston KL, Pilkonis PA. Development of short forms from the PROMIS™ sleep disturbance and Sleep-Related Impairment item banks. Behav Sleep Med. 2011 Dec 28;10(1):6-24. |
4 weeks | |
| Secondary | Sleep quality | Sleep quality, measured by the PROMIS Sleep Disturbances and Sleep-related impairment questionnaires Yu L, Buysse DJ, Germain A, Moul DE, Stover A, Dodds NE, Johnston KL, Pilkonis PA. Development of short forms from the PROMIS™ sleep disturbance and Sleep-Related Impairment item banks. Behav Sleep Med. 2011 Dec 28;10(1):6-24. |
12 weeks | |
| Secondary | Mindfulness | Mindfulness, measured by the Conscious Presence and Self Control Instruments Büssing A, Walach H, Kohls N, Zimmermann F, Trousselard M. Conscious Presence and Self Control as a measure of situational awareness in soldiers - A validation study. International Journal of Mental Health Systems 2013, 7:1 |
4 weeks | |
| Secondary | Mindfulness | Mindfulness, measured by the Conscious Presence and Self Control Instruments Büssing A, Walach H, Kohls N, Zimmermann F, Trousselard M. Conscious Presence and Self Control as a measure of situational awareness in soldiers - A validation study. International Journal of Mental Health Systems 2013, 7:1 |
12 weeks | |
| Secondary | Inner Peace | Inner Peace, measured by the Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being Scale (FACIT-Sp) Peterman AH, Fitchett G, Brady MJ, Hernandez L, Cella D: Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy - Spiritual Well-being Scale (FACIT-Sp). Ann Behav Med 2002, 24:49-58. |
4 weeks | |
| Secondary | Inner Peace | Inner Peace, measured by the Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being Scale (FACIT-Sp) Peterman AH, Fitchett G, Brady MJ, Hernandez L, Cella D: Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy - Spiritual Well-being Scale (FACIT-Sp). Ann Behav Med 2002, 24:49-58. |
12 weeks | |
| Secondary | Ease of life | Ease of life, measured by the Emotional and rational disease acceptance questionnaire (ERDA) Büssing A, Matthiessen PF, Mundle G. Emotional and rational disease acceptance in patients with depression and alcohol addiction. BMC Health and Quality of Life Outcomes 2008; 6:4. |
4 weeks | |
| Secondary | Ease of life | Ease of life, measured by the Emotional and rational disease acceptance questionnaire (ERDA) Büssing A, Matthiessen PF, Mundle G. Emotional and rational disease acceptance in patients with depression and alcohol addiction. BMC Health and Quality of Life Outcomes 2008; 6:4. |
12 weeks | |
| Secondary | Body weight | Body weight in kg | 4 weeks | |
| Secondary | Body weight | Body weight in kg | 12 weeks | |
| Secondary | Body fat | Body fat, measured using a Bioelectrical impedance analysis scale | 4 weeks | |
| Secondary | Body fat | Body fat, measured using a Bioelectrical impedance analysis scale | 12 weeks | |
| Secondary | Waist circumference | Waist circumference in cm | 4 weeks | |
| Secondary | Waist circumference | Waist circumference in cm | 12 weeks | |
| Secondary | Hip circumference | Hip circumference | 4 weeks | |
| Secondary | Hip circumference | Hip circumference | 12 weeks | |
| Secondary | Blood pressure | Blood pressure, measured using an automatic device | 4 weeks | |
| Secondary | Blood pressure | Blood pressure, measured using an automatic device | 12 weeks | |
| Secondary | Heart rate | Heart rate, measured using an automatic device | 4 weeks | |
| Secondary | Heart rate | Heart rate, measured using an automatic device | 12 weeks | |
| Secondary | Compliance | Compliance, measured using a structured interview about nutrition during Ramadan | 4 weeks | |
| Secondary | Adverse events | adverse events during the study period | 4 weeks | |
| Secondary | Blood lipid level | Blood lipid level, including serum measures triglycerides, cholesterol, HDL and LDL cholesterol | 4 weeks | |
| Secondary | Blood glucose level | Blood glucose level, serum measure | 4 weeks | |
| Secondary | AST/SGOT | AST/SGOT, as measure of liver function | 4 weeks | |
| Secondary | ALT/SGPT | ALT/SGPT, as measure of liver function | 4 weeks | |
| Secondary | GGT | GGT, as measure of liver function | 4 weeks | |
| Secondary | Uric acid level | Uric acid level, serum measure | 4 weeks | |
| Secondary | Creatinine | Creatinine level, serum measure | 4 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
| Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
| Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
| Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
| Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
| Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
| Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
| Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
| Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
| Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
| Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
| Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
| Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
| Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
| Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
| Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
| Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |